Abiopharma

Financial Statements and Related Announcement: Half Yearly Results

Auxly Reports Second Quarter 2026 Results

Clearmind Advances CMND-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

Financial Statements and Related Announcement: Half Yearly Results

Interested Person Transaction: Interested Person Transaction pursuant to Catalist Rule 905(2)

IREN Delivers Horizon 1 to Microsoft and Achieves NVIDIA Exemplar Cloud Status on GB300 NVL72

AFC Announces Financial Results for the Second Quarter 2026

Karyopharm Reports Second Quarter 2026 Financial Results and Highlights Continued Progress Toward Myelofibrosis sNDA Submission

Abeona Therapeutics® Reports Second Quarter 2026 Results and Provides Business Update

Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update